APO Research
Talk to an analyst

APO RESEARCH · REPORT

Malaria Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Research

Malaria Vaccines Industry Research Report 2026

22 December 2025144 pages

Choose your research edition.

Industry ResearchMalaria Vaccines Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Malaria Vaccines Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Malaria Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Malaria Vaccines Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Malaria Vaccines Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Malaria Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Malaria Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Malaria Vaccines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Malaria Vaccines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Malaria Vaccines include Sanofi, Novartis AG, Mylan N.V., Pfizer Inc, GlaxoSmithKline Plc, Zydus Cadila, VLP Therapeutics, Taj Pharmaceuticals Limited and Sun Pharmaceutical Industries Ltd, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Malaria Vaccines market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Malaria Vaccines.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Malaria Vaccines Market by Company

Sanofi

Novartis AG

Mylan N.V.

Pfizer Inc

GlaxoSmithKline Plc

Zydus Cadila

VLP Therapeutics

Taj Pharmaceuticals Limited

Sun Pharmaceutical Industries Ltd

Sumaya Biotech

Strides Pharma Science Limited

Sanaria Inc

OSIVAX

Nobelpharma Co

Lupin

Ipca Laboratories Ltd

Hikma Pharmaceuticals PLC

GeoVax

GenVec

Cipla Inc

CellFree Sciences

Bliss GVS Pharma Ltd

Amneal Pharmaceuticals LLC

AJANTA PHARMA

AdvaCare Pharma

Actiza Pharmaceutical Private Limited

Malaria Vaccines Segment by Type

Erythrocytic Vaccine

Pre-Erythrocytic Vaccine

Multi-antigen Vaccine

Malaria Vaccines Segment by Application

Clinics

Hospitals

Community Centers

Malaria Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Malaria Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Malaria Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Malaria Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Malaria Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Malaria Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Malaria Vaccines Revenue Market Share by Type (2021-2026) Table 7. Global Malaria Vaccines Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Malaria Vaccines Revenue Market Share by Type (2027-2032) Table 9. Global Malaria Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Malaria Vaccines Revenue Market Share by Application (2021-2026) Table 11. Global Malaria Vaccines Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Malaria Vaccines Revenue Market Share by Application (2027-2032) Table 13. Global Malaria Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Malaria Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Malaria Vaccines Market Share by Region (2021-2026) Table 16. Global Malaria Vaccines Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Malaria Vaccines Market Share by Region (2027-2032) Table 18. Malaria Vaccines Industry Trends Table 19. Malaria Vaccines Industry Drivers Table 20. Malaria Vaccines Industry Opportunities and Challenges Table 21. Malaria Vaccines Market Restraints Table 22. Global Top Malaria Vaccines Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Malaria Vaccines Revenue Market Share by Players (2021-2026) Table 24. Global Malaria Vaccines Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Malaria Vaccines, Headquarters and Area Served Table 26. Global Malaria Vaccines Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Malaria Vaccines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Malaria Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Malaria Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Malaria Vaccines Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Malaria Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Malaria Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Malaria Vaccines Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Malaria Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Malaria Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Malaria Vaccines Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Malaria Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Malaria Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Malaria Vaccines Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Malaria Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Malaria Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Malaria Vaccines Market Size by Country (2027-2032) & (US$ Million) Table 45. Sanofi Company Information Table 46. Sanofi Business Overview Table 47. Sanofi Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 48. Sanofi Malaria Vaccines Product Portfolio Table 49. Sanofi Recent Developments Table 50. Novartis AG Company Information Table 51. Novartis AG Business Overview Table 52. Novartis AG Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 53. Novartis AG Malaria Vaccines Product Portfolio Table 54. Novartis AG Recent Developments Table 55. Mylan N.V. Company Information Table 56. Mylan N.V. Business Overview Table 57. Mylan N.V. Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 58. Mylan N.V. Malaria Vaccines Product Portfolio Table 59. Mylan N.V. Recent Developments Table 60. Pfizer Inc Company Information Table 61. Pfizer Inc Business Overview Table 62. Pfizer Inc Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 63. Pfizer Inc Malaria Vaccines Product Portfolio Table 64. Pfizer Inc Recent Developments Table 65. GlaxoSmithKline Plc Company Information Table 66. GlaxoSmithKline Plc Business Overview Table 67. GlaxoSmithKline Plc Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 68. GlaxoSmithKline Plc Malaria Vaccines Product Portfolio Table 69. GlaxoSmithKline Plc Recent Developments Table 70. Zydus Cadila Company Information Table 71. Zydus Cadila Business Overview Table 72. Zydus Cadila Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 73. Zydus Cadila Malaria Vaccines Product Portfolio Table 74. Zydus Cadila Recent Developments Table 75. VLP Therapeutics Company Information Table 76. VLP Therapeutics Business Overview Table 77. VLP Therapeutics Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 78. VLP Therapeutics Malaria Vaccines Product Portfolio Table 79. VLP Therapeutics Recent Developments Table 80. Taj Pharmaceuticals Limited Company Information Table 81. Taj Pharmaceuticals Limited Business Overview Table 82. Taj Pharmaceuticals Limited Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 83. Taj Pharmaceuticals Limited Malaria Vaccines Product Portfolio Table 84. Taj Pharmaceuticals Limited Recent Developments Table 85. Sun Pharmaceutical Industries Ltd Company Information Table 86. Sun Pharmaceutical Industries Ltd Business Overview Table 87. Sun Pharmaceutical Industries Ltd Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 88. Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Portfolio Table 89. Sun Pharmaceutical Industries Ltd Recent Developments Table 90. Sumaya Biotech Company Information Table 91. Sumaya Biotech Business Overview Table 92. Sumaya Biotech Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 93. Sumaya Biotech Malaria Vaccines Product Portfolio Table 94. Sumaya Biotech Recent Developments Table 95. Strides Pharma Science Limited Company Information Table 96. Strides Pharma Science Limited Business Overview Table 97. Strides Pharma Science Limited Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 98. Strides Pharma Science Limited Malaria Vaccines Product Portfolio Table 99. Strides Pharma Science Limited Recent Developments Table 100. Sanaria Inc Company Information Table 101. Sanaria Inc Business Overview Table 102. Sanaria Inc Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 103. Sanaria Inc Malaria Vaccines Product Portfolio Table 104. Sanaria Inc Recent Developments Table 105. OSIVAX Company Information Table 106. OSIVAX Business Overview Table 107. OSIVAX Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 108. OSIVAX Malaria Vaccines Product Portfolio Table 109. OSIVAX Recent Developments Table 110. Nobelpharma Co Company Information Table 111. Nobelpharma Co Business Overview Table 112. Nobelpharma Co Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 113. Nobelpharma Co Malaria Vaccines Product Portfolio Table 114. Nobelpharma Co Recent Developments Table 115. Lupin Company Information Table 116. Lupin Business Overview Table 117. Lupin Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 118. Lupin Malaria Vaccines Product Portfolio Table 119. Lupin Recent Developments Table 120. Ipca Laboratories Ltd Company Information Table 121. Ipca Laboratories Ltd Business Overview Table 122. Ipca Laboratories Ltd Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 123. Ipca Laboratories Ltd Malaria Vaccines Product Portfolio Table 124. Ipca Laboratories Ltd Recent Developments Table 125. Hikma Pharmaceuticals PLC Company Information Table 126. Hikma Pharmaceuticals PLC Business Overview Table 127. Hikma Pharmaceuticals PLC Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 128. Hikma Pharmaceuticals PLC Malaria Vaccines Product Portfolio Table 129. Hikma Pharmaceuticals PLC Recent Developments Table 130. GeoVax Company Information Table 131. GeoVax Business Overview Table 132. GeoVax Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 133. GeoVax Malaria Vaccines Product Portfolio Table 134. GeoVax Recent Developments Table 135. GenVec Company Information Table 136. GenVec Business Overview Table 137. GenVec Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 138. GenVec Malaria Vaccines Product Portfolio Table 139. GenVec Recent Developments Table 140. Cipla Inc Company Information Table 141. Cipla Inc Business Overview Table 142. Cipla Inc Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 143. Cipla Inc Malaria Vaccines Product Portfolio Table 144. Cipla Inc Recent Developments Table 145. CellFree Sciences Company Information Table 146. CellFree Sciences Business Overview Table 147. CellFree Sciences Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 148. CellFree Sciences Malaria Vaccines Product Portfolio Table 149. CellFree Sciences Recent Developments Table 150. Bliss GVS Pharma Ltd Company Information Table 151. Bliss GVS Pharma Ltd Business Overview Table 152. Bliss GVS Pharma Ltd Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 153. Bliss GVS Pharma Ltd Malaria Vaccines Product Portfolio Table 154. Bliss GVS Pharma Ltd Recent Developments Table 155. Amneal Pharmaceuticals LLC Company Information Table 156. Amneal Pharmaceuticals LLC Business Overview Table 157. Amneal Pharmaceuticals LLC Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 158. Amneal Pharmaceuticals LLC Malaria Vaccines Product Portfolio Table 159. Amneal Pharmaceuticals LLC Recent Developments Table 160. AJANTA PHARMA Company Information Table 161. AJANTA PHARMA Business Overview Table 162. AJANTA PHARMA Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 163. AJANTA PHARMA Malaria Vaccines Product Portfolio Table 164. AJANTA PHARMA Recent Developments Table 165. AdvaCare Pharma Company Information Table 166. AdvaCare Pharma Business Overview Table 167. AdvaCare Pharma Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 168. AdvaCare Pharma Malaria Vaccines Product Portfolio Table 169. AdvaCare Pharma Recent Developments Table 170. Actiza Pharmaceutical Private Limited Company Information Table 171. Actiza Pharmaceutical Private Limited Business Overview Table 172. Actiza Pharmaceutical Private Limited Revenue in Malaria Vaccines Business (2021-2026) & (US$ Million) Table 173. Actiza Pharmaceutical Private Limited Malaria Vaccines Product Portfolio Table 174. Actiza Pharmaceutical Private Limited Recent Developments Table 175. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Malaria Vaccines Product Image Figure 5. Global Malaria Vaccines Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Malaria Vaccines Market Share by Type: 2025 VS 2032 Figure 7. Erythrocytic Vaccine Product Figure 8. Pre-Erythrocytic Vaccine Product Figure 9. Multi-antigen Vaccine Product Figure 10. Global Malaria Vaccines Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Malaria Vaccines Market Share by Application: 2025 VS 2032 Figure 12. Clinics Product Figure 13. Hospitals Product Figure 14. Community Centers Product Figure 15. Global Malaria Vaccines Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global Malaria Vaccines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Malaria Vaccines Market Share by Region: 2025 VS 2032 Figure 18. Global Malaria Vaccines Market Share by Players in 2025 Figure 19. Global Malaria Vaccines Manufacturers Established Date Figure 20. Global Top 5 and 10 Malaria Vaccines Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Malaria Vaccines Market Share by Country (2021-2032) Figure 24. United States Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico Malaria Vaccines Market Share by Country (2021-2032) Figure 27. Europe Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe Malaria Vaccines Market Share by Country (2021-2032) Figure 29. Germany Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Malaria Vaccines Market Share by Country (2021-2032) Figure 39. China Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Malaria Vaccines Market Share by Country (2021-2032) Figure 44. Australia Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Malaria Vaccines Market Share by Country (2021-2032) Figure 49. Brazil Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru Malaria Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Sanofi Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 55. Novartis AG Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 56. Mylan N.V. Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 57. Pfizer Inc Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 58. GlaxoSmithKline Plc Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 59. Zydus Cadila Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 60. VLP Therapeutics Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 61. Taj Pharmaceuticals Limited Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 62. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 63. Sumaya Biotech Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 64. Strides Pharma Science Limited Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 65. Sanaria Inc Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 66. OSIVAX Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 67. Nobelpharma Co Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 68. Lupin Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 69. Ipca Laboratories Ltd Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 70. Hikma Pharmaceuticals PLC Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 71. GeoVax Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 72. GenVec Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 73. Cipla Inc Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 74. CellFree Sciences Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 75. Bliss GVS Pharma Ltd Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 76. Amneal Pharmaceuticals LLC Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 77. AJANTA PHARMA Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 78. AdvaCare Pharma Revenue Growth Rate in Malaria Vaccines Business (2021-2026) Figure 79. Actiza Pharmaceutical Private Limited Revenue Growth Rate in Malaria Vaccines Business (2021-2026)

Scope & coverage.

Types
  • Erythrocytic Vaccine
  • Pre-Erythrocytic Vaccine
  • Multi-antigen Vaccine
Applications
  • Clinics
  • Hospitals
  • Community Centers
Companies covered
  • Sanofi
  • Novartis AG
  • Mylan N.V.
  • Pfizer Inc
  • GlaxoSmithKline Plc
  • Zydus Cadila
  • VLP Therapeutics
  • Taj Pharmaceuticals Limited
  • Sun Pharmaceutical Industries Ltd
  • Sumaya Biotech
  • Strides Pharma Science Limited
  • Sanaria Inc
  • OSIVAX
  • Nobelpharma Co
  • Lupin
  • Ipca Laboratories Ltd
  • Hikma Pharmaceuticals PLC
  • GeoVax
  • GenVec
  • Cipla Inc
  • CellFree Sciences
  • Bliss GVS Pharma Ltd
  • Amneal Pharmaceuticals LLC
  • AJANTA PHARMA
  • AdvaCare Pharma
  • Actiza Pharmaceutical Private Limited

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Malaria Vaccines by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Erythrocytic Vaccine
  5. 2.2.3 Pre-Erythrocytic Vaccine
  6. 2.2.4 Multi-antigen Vaccine
  7. 2.3 Malaria Vaccines by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  9. 2.3.2 Clinics
  10. 2.3.3 Hospitals
  11. 2.3.4 Community Centers
  12. 2.4 Assumptions and Limitations
3 Malaria Vaccines Breakdown Data by Type
  1. 3.1 Global Malaria Vaccines Historic Market Size by Type (2021-2026)
  2. 3.2 Global Malaria Vaccines Forecasted Market Size by Type (2027-2032)
4 Malaria Vaccines Breakdown Data by Application
  1. 4.1 Global Malaria Vaccines Historic Market Size by Application (2021-2026)
  2. 4.2 Global Malaria Vaccines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Malaria Vaccines Market Perspective (2021-2032)
  2. 5.2 Global Malaria Vaccines Growth Trends by Region
  3. 5.2.1 Global Malaria Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Malaria Vaccines Historic Market Size by Region (2021-2026)
  5. 5.2.3 Malaria Vaccines Forecasted Market Size by Region (2027-2032)
  6. 5.3 Malaria Vaccines Market Dynamics
  7. 5.3.1 Malaria Vaccines Industry Trends
  8. 5.3.2 Malaria Vaccines Market Drivers
  9. 5.3.3 Malaria Vaccines Market Challenges
  10. 5.3.4 Malaria Vaccines Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Malaria Vaccines Players by Revenue
  2. 6.1.1 Global Top Malaria Vaccines Players by Revenue (2021-2026)
  3. 6.1.2 Global Malaria Vaccines Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Malaria Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Malaria Vaccines Head Office and Area Served
  6. 6.4 Global Malaria Vaccines Players, Product Type & Application
  7. 6.5 Global Malaria Vaccines Manufacturers Established Date
  8. 6.6 Global Malaria Vaccines Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Malaria Vaccines Market Size (2021-2032)
  2. 7.2 North America Malaria Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Malaria Vaccines Market Size by Country (2021-2026)
  4. 7.4 North America Malaria Vaccines Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Malaria Vaccines Market Size (2021-2032)
  2. 8.2 Europe Malaria Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Malaria Vaccines Market Size by Country (2021-2026)
  4. 8.4 Europe Malaria Vaccines Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Malaria Vaccines Market Size (2021-2032)
  2. 9.2 Asia-Pacific Malaria Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Malaria Vaccines Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Malaria Vaccines Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Malaria Vaccines Market Size (2021-2032)
  2. 10.2 South America Malaria Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Malaria Vaccines Market Size by Country (2021-2026)
  4. 10.4 South America Malaria Vaccines Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Malaria Vaccines Market Size (2021-2032)
  2. 11.2 Middle East & Africa Malaria Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Malaria Vaccines Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Malaria Vaccines Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Sanofi
  2. 12.1.1 Sanofi Company Information
  3. 12.1.2 Sanofi Business Overview
  4. 12.1.3 Sanofi Revenue in Malaria Vaccines Business (2021-2026)
  5. 12.1.4 Sanofi Malaria Vaccines Product Portfolio
  6. 12.1.5 Sanofi Recent Developments
  7. 12.2 Novartis AG
  8. 12.2.1 Novartis AG Company Information
  9. 12.2.2 Novartis AG Business Overview
  10. 12.2.3 Novartis AG Revenue in Malaria Vaccines Business (2021-2026)
  11. 12.2.4 Novartis AG Malaria Vaccines Product Portfolio
  12. 12.2.5 Novartis AG Recent Developments
  13. 12.3 Mylan N.V.
  14. 12.3.1 Mylan N.V. Company Information
  15. 12.3.2 Mylan N.V. Business Overview
  16. 12.3.3 Mylan N.V. Revenue in Malaria Vaccines Business (2021-2026)
  17. 12.3.4 Mylan N.V. Malaria Vaccines Product Portfolio
  18. 12.3.5 Mylan N.V. Recent Developments
  19. 12.4 Pfizer Inc
  20. 12.4.1 Pfizer Inc Company Information
  21. 12.4.2 Pfizer Inc Business Overview
  22. 12.4.3 Pfizer Inc Revenue in Malaria Vaccines Business (2021-2026)
  23. 12.4.4 Pfizer Inc Malaria Vaccines Product Portfolio
  24. 12.4.5 Pfizer Inc Recent Developments
  25. 12.5 GlaxoSmithKline Plc
  26. 12.5.1 GlaxoSmithKline Plc Company Information
  27. 12.5.2 GlaxoSmithKline Plc Business Overview
  28. 12.5.3 GlaxoSmithKline Plc Revenue in Malaria Vaccines Business (2021-2026)
  29. 12.5.4 GlaxoSmithKline Plc Malaria Vaccines Product Portfolio
  30. 12.5.5 GlaxoSmithKline Plc Recent Developments
  31. 12.6 Zydus Cadila
  32. 12.6.1 Zydus Cadila Company Information
  33. 12.6.2 Zydus Cadila Business Overview
  34. 12.6.3 Zydus Cadila Revenue in Malaria Vaccines Business (2021-2026)
  35. 12.6.4 Zydus Cadila Malaria Vaccines Product Portfolio
  36. 12.6.5 Zydus Cadila Recent Developments
  37. 12.7 VLP Therapeutics
  38. 12.7.1 VLP Therapeutics Company Information
  39. 12.7.2 VLP Therapeutics Business Overview
  40. 12.7.3 VLP Therapeutics Revenue in Malaria Vaccines Business (2021-2026)
  41. 12.7.4 VLP Therapeutics Malaria Vaccines Product Portfolio
  42. 12.7.5 VLP Therapeutics Recent Developments
  43. 12.8 Taj Pharmaceuticals Limited
  44. 12.8.1 Taj Pharmaceuticals Limited Company Information
  45. 12.8.2 Taj Pharmaceuticals Limited Business Overview
  46. 12.8.3 Taj Pharmaceuticals Limited Revenue in Malaria Vaccines Business (2021-2026)
  47. 12.8.4 Taj Pharmaceuticals Limited Malaria Vaccines Product Portfolio
  48. 12.8.5 Taj Pharmaceuticals Limited Recent Developments
  49. 12.9 Sun Pharmaceutical Industries Ltd
  50. 12.9.1 Sun Pharmaceutical Industries Ltd Company Information
  51. 12.9.2 Sun Pharmaceutical Industries Ltd Business Overview
  52. 12.9.3 Sun Pharmaceutical Industries Ltd Revenue in Malaria Vaccines Business (2021-2026)
  53. 12.9.4 Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Portfolio
  54. 12.9.5 Sun Pharmaceutical Industries Ltd Recent Developments
  55. 12.10 Sumaya Biotech
  56. 12.10.1 Sumaya Biotech Company Information
  57. 12.10.2 Sumaya Biotech Business Overview
  58. 12.10.3 Sumaya Biotech Revenue in Malaria Vaccines Business (2021-2026)
  59. 12.10.4 Sumaya Biotech Malaria Vaccines Product Portfolio
  60. 12.10.5 Sumaya Biotech Recent Developments
  61. 12.11 Strides Pharma Science Limited
  62. 12.11.1 Strides Pharma Science Limited Company Information
  63. 12.11.2 Strides Pharma Science Limited Business Overview
  64. 12.11.3 Strides Pharma Science Limited Revenue in Malaria Vaccines Business (2021-2026)
  65. 12.11.4 Strides Pharma Science Limited Malaria Vaccines Product Portfolio
  66. 12.11.5 Strides Pharma Science Limited Recent Developments
  67. 12.12 Sanaria Inc
  68. 12.12.1 Sanaria Inc Company Information
  69. 12.12.2 Sanaria Inc Business Overview
  70. 12.12.3 Sanaria Inc Revenue in Malaria Vaccines Business (2021-2026)
  71. 12.12.4 Sanaria Inc Malaria Vaccines Product Portfolio
  72. 12.12.5 Sanaria Inc Recent Developments
  73. 12.13 OSIVAX
  74. 12.13.1 OSIVAX Company Information
  75. 12.13.2 OSIVAX Business Overview
  76. 12.13.3 OSIVAX Revenue in Malaria Vaccines Business (2021-2026)
  77. 12.13.4 OSIVAX Malaria Vaccines Product Portfolio
  78. 12.13.5 OSIVAX Recent Developments
  79. 12.14 Nobelpharma Co
  80. 12.14.1 Nobelpharma Co Company Information
  81. 12.14.2 Nobelpharma Co Business Overview
  82. 12.14.3 Nobelpharma Co Revenue in Malaria Vaccines Business (2021-2026)
  83. 12.14.4 Nobelpharma Co Malaria Vaccines Product Portfolio
  84. 12.14.5 Nobelpharma Co Recent Developments
  85. 12.15 Lupin
  86. 12.15.1 Lupin Company Information
  87. 12.15.2 Lupin Business Overview
  88. 12.15.3 Lupin Revenue in Malaria Vaccines Business (2021-2026)
  89. 12.15.4 Lupin Malaria Vaccines Product Portfolio
  90. 12.15.5 Lupin Recent Developments
  91. 12.16 Ipca Laboratories Ltd
  92. 12.16.1 Ipca Laboratories Ltd Company Information
  93. 12.16.2 Ipca Laboratories Ltd Business Overview
  94. 12.16.3 Ipca Laboratories Ltd Revenue in Malaria Vaccines Business (2021-2026)
  95. 12.16.4 Ipca Laboratories Ltd Malaria Vaccines Product Portfolio
  96. 12.16.5 Ipca Laboratories Ltd Recent Developments
  97. 12.17 Hikma Pharmaceuticals PLC
  98. 12.17.1 Hikma Pharmaceuticals PLC Company Information
  99. 12.17.2 Hikma Pharmaceuticals PLC Business Overview
  100. 12.17.3 Hikma Pharmaceuticals PLC Revenue in Malaria Vaccines Business (2021-2026)
  101. 12.17.4 Hikma Pharmaceuticals PLC Malaria Vaccines Product Portfolio
  102. 12.17.5 Hikma Pharmaceuticals PLC Recent Developments
  103. 12.18 GeoVax
  104. 12.18.1 GeoVax Company Information
  105. 12.18.2 GeoVax Business Overview
  106. 12.18.3 GeoVax Revenue in Malaria Vaccines Business (2021-2026)
  107. 12.18.4 GeoVax Malaria Vaccines Product Portfolio
  108. 12.18.5 GeoVax Recent Developments
  109. 12.19 GenVec
  110. 12.19.1 GenVec Company Information
  111. 12.19.2 GenVec Business Overview
  112. 12.19.3 GenVec Revenue in Malaria Vaccines Business (2021-2026)
  113. 12.19.4 GenVec Malaria Vaccines Product Portfolio
  114. 12.19.5 GenVec Recent Developments
  115. 12.20 Cipla Inc
  116. 12.20.1 Cipla Inc Company Information
  117. 12.20.2 Cipla Inc Business Overview
  118. 12.20.3 Cipla Inc Revenue in Malaria Vaccines Business (2021-2026)
  119. 12.20.4 Cipla Inc Malaria Vaccines Product Portfolio
  120. 12.20.5 Cipla Inc Recent Developments
  121. 12.21 CellFree Sciences
  122. 12.21.1 CellFree Sciences Company Information
  123. 12.21.2 CellFree Sciences Business Overview
  124. 12.21.3 CellFree Sciences Revenue in Malaria Vaccines Business (2021-2026)
  125. 12.21.4 CellFree Sciences Malaria Vaccines Product Portfolio
  126. 12.21.5 CellFree Sciences Recent Developments
  127. 12.22 Bliss GVS Pharma Ltd
  128. 12.22.1 Bliss GVS Pharma Ltd Company Information
  129. 12.22.2 Bliss GVS Pharma Ltd Business Overview
  130. 12.22.3 Bliss GVS Pharma Ltd Revenue in Malaria Vaccines Business (2021-2026)
  131. 12.22.4 Bliss GVS Pharma Ltd Malaria Vaccines Product Portfolio
  132. 12.22.5 Bliss GVS Pharma Ltd Recent Developments
  133. 12.23 Amneal Pharmaceuticals LLC
  134. 12.23.1 Amneal Pharmaceuticals LLC Company Information
  135. 12.23.2 Amneal Pharmaceuticals LLC Business Overview
  136. 12.23.3 Amneal Pharmaceuticals LLC Revenue in Malaria Vaccines Business (2021-2026)
  137. 12.23.4 Amneal Pharmaceuticals LLC Malaria Vaccines Product Portfolio
  138. 12.23.5 Amneal Pharmaceuticals LLC Recent Developments
  139. 12.24 AJANTA PHARMA
  140. 12.24.1 AJANTA PHARMA Company Information
  141. 12.24.2 AJANTA PHARMA Business Overview
  142. 12.24.3 AJANTA PHARMA Revenue in Malaria Vaccines Business (2021-2026)
  143. 12.24.4 AJANTA PHARMA Malaria Vaccines Product Portfolio
  144. 12.24.5 AJANTA PHARMA Recent Developments
  145. 12.25 AdvaCare Pharma
  146. 12.25.1 AdvaCare Pharma Company Information
  147. 12.25.2 AdvaCare Pharma Business Overview
  148. 12.25.3 AdvaCare Pharma Revenue in Malaria Vaccines Business (2021-2026)
  149. 12.25.4 AdvaCare Pharma Malaria Vaccines Product Portfolio
  150. 12.25.5 AdvaCare Pharma Recent Developments
  151. 12.26 Actiza Pharmaceutical Private Limited
  152. 12.26.1 Actiza Pharmaceutical Private Limited Company Information
  153. 12.26.2 Actiza Pharmaceutical Private Limited Business Overview
  154. 12.26.3 Actiza Pharmaceutical Private Limited Revenue in Malaria Vaccines Business (2021-2026)
  155. 12.26.4 Actiza Pharmaceutical Private Limited Malaria Vaccines Product Portfolio
  156. 12.26.5 Actiza Pharmaceutical Private Limited Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst